Health care utilization in frontotemporal lobar degeneration

Alzheimer Disease and Associated Disorders

Volumn 26, Issue 2, 2012, Pages 166-170

  Diehl Schmid, Janine ^a   Last, Dirk ^a,b   Schuster, Tibor ^a   Förstl, Hans ^a   Schneider Schelte, Helga ^c   Kurz, Alexander ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Kreiskrankenhaus Erding   (Germany)

^c Deutsche Alzheimer Gesellschaft   (Germany)

Author keywords

caregiver; frontotemporal dementia; frontotemporal lobar degeneration; health care utilization; support

Indexed keywords

MEMANTINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CAREGIVER SUPPORT; DAILY LIFE ACTIVITY; DEATH; FEMALE; FRONTOTEMPORAL DEMENTIA; HEALTH CARE UTILIZATION; HOME CARE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORTALITY; NURSING HOME; NURSING HOME PATIENT; PATIENT CARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CAREGIVERS; DELIVERY OF HEALTH CARE; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HOME NURSING; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NURSING HOMES;

EID: 84861455683     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e3182263edc     Document Type: Article

References (26)

1. Rosso S. Frontotemporal Dementia in the Netherlands: Patient Characteristics and Prevalence Estimates from a Population-based Study. Rotterdam: Optima Grafische Communicatie; 2003.
2. Borroni B., Alberici A., Grassi M., et al. Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia County., Italy. J Alzheimer Dis. 2010;19:111-116.
3. Barker W., Luis C., Kashuba A., et al. Relative frequencies of Alzheimer's Disease., Lewy body., vascular and frontotemporal dementia., and hippocampal sclerosis in the State of Florida brain bank. Alzheimer Dis Assoc Disord. 2002;16:203-212. (Pubitemid 35434796)
4. Mercy L., Hodges J., Dawson K., et al. Incidence of early-onset dementia in Cambridgeshire., United Kingdom. Neurology. 2008;71:1496-1499.
5. Rabinovici GD., Miller BL. Frontotemporal lobar degeneration: epidemiology., pathophysiology., diagnosis and management. CNS Drugs. 2010;24:375-398.
6. Johnson J., Diehl J., Mendez M., et al. Frontotemporal lobar degeneration: demographic characteristics among 353 patients. Arch Neurol. 2005;62:925-930. (Pubitemid 40973454)
7. Mackenzie IR., Foti D., Woulfe J., et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive., TDP-43-negative neuronal inclusions. Brain. 2008;131:1282-1293.
8. Roberson E., Hesse J., Rose K., et al. Frontotemporal dementia progresses to death faster than Alzheimer's Disease. Neurology. 2005;65:719-725. (Pubitemid 41285851)
9. Hodges J., Davies R., Xuereb J., et al. Survival in frontotemporal dementia. Neurology. 2003;61:349-354. (Pubitemid 36975964)
10. Diehl-Schmid J., Pohl C., Perneczky R., et al. Initial symptoms., survival and causes of death in 115 patients with frontotemporal lobar degeneration. Fortschr Neurol Psychiatr. 2006; 75:708-713.
11. Neary D., Snowden J., Gustafson L., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
12. Piguet O., Hornberger M., Mioshi E., et al. Behavioural-variant frontotemporal dementia: diagnosis., clinical staging., and management. Lancet Neurol. 2011;10:162-172.
13. Gorno-Tempini ML., Hillis AE., Weintraub S., et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-1014.
14. Le Rhun E., Richard F., Pasquier F. Natural history of primary progressive aphasia. Neurology. 2005;65:887-891. (Pubitemid 41362135)
15. Riedijk S., Duivenvoorden H., Oostrom I., et al. Frontotemporal dementia patients living at home and their spousal caregivers compared with institutionalized FTD patients and their spousal caregivers. Dementia. 2009;8:61-77.
16. Nicolaou P., Egan S., Gasson N., et al. Identifying needs., burden., and distress of carers of people witth frontotemporal dementia compared to Alzheimer's disease. Dementia. 2010;9:215.
17. Rosness T., Haugen P., Engedal K. Support to family carers of patients with frontotemporal dementia. Aging Mental Health. 2008;12:462-466.
18. Chemali Z., Withall A., Daffner KR. The plight of caring for young patients with frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2010;25:109-115.
19. Pijnenburg Y., Sampson E., Harvey R., et al. Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. Int J Geriatr Psychiatry. 2003;18:67-72. (Pubitemid 36131229)
20. Practice guide NICE/SCIE Supporting people with dementia and their carers in health and social care. 2006.
21. Diehl-Schmid J., Neumann M., Laws SM., et al. Frontotemporal lobar degeneration. Fortschr Neurol Psychiatr. 2009;77: 295-304.
22. Hu B., Ross L., Neuhaus J., et al. Off-label medication use in frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2010;25:128-133.
23. Diehl-Schmid J., Förstl H., Perneczky R., et al. A 6-month., open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry. 2008;23: 754-759.
24. Huey E., Putnam K., Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17-22. (Pubitemid 43739585)
25. Mann E., Köpke S., Haastert B., et al. Psychotropic medication use among nursing home residents in austria: a cross-sectional study. BMC Geriatrics. 2009;9:18.
26. Fitzpatrick AL., Kuller LH., Lopez OL., et al. Survival following dementia onset: Alzheimer's Disease and vascular dementia. J Neurol Sci. 2005;229-230:43-49. (Pubitemid 40341563)